Oral Session 2-13B MDS：Clinical (1)

[OS2-13B-2] Clinical features and cytogenetic aberrations in A-bomb induced MDS with complex karyotype

Makiko Horai¹, Shinya Sato¹, Masatoshi Matsuo², Masako Iwanaga³, Kensuke Horio⁴, Tatsuro Jo⁴, Yumi Takasaki⁵, Yasuhisa Kawaguchi², Hideki Tsushima², Shinichiro Yoshida⁶, Masataka Taguchi¹, Koji Ando¹, Yasushi Sawayama¹, Yoshitaka Imaizumi¹, Tomoko Hata¹, Yukiyoshi Moriuchi⁷, Yasushi Miyazaki¹ (1.Haematology, Nagasaki University Hospital, Nagasaki, japan, 2.Hematology Nagasaki Harbor Medical Center, Nagasaki, Japan, 3.Department of Frontier Life Sciences, Nagasaki University, Nagasaki, Japan, 4.Hematology, Japanese Red Cross Nagasakai Genbaku Hospital, Nagasaki, Japan, 5.Saint Francis Hospital, Nagasaki, Japan, 6.Hematology, National Hospital Organization Nagasaki Medical Center, Omura, Japan, 7.Hematology, Sasebo City General Center, Sasebo, Japan)